Pre-metastatic niche (PMN)

The pre-metastatic niche (PMN) represents a specialized microenvironment in distant organs that is prepared by the primary tumor to facilitate the survival and outgrowth of disseminated tumor cells (DTCs). This 'priming' process occurs before the arrival of cancer cells and is mediated by tumor-secreted factors, including cytokines, growth factors, and extracellular vesicles such as exosomes (Peinado et al., 2017, Nature Reviews Cancer). These factors lead to significant extracellular matrix (ECM) remodeling, the recruitment of bone marrow-derived cells (BMDCs), and the creation of an immunosuppressive environment (Liu & Cao, 2016, Cancer Cell). Therapeutic intervention aimed at the PMN seeks to 'de-prime' the site by inhibiting key mediators like lysyl oxidase (LOX) or blocking the recruitment of myeloid-derived suppressor cells (MDSCs) (Kaplan et al., 2005, Nature). Although it is a complex microenvironment rather than a single molecular target, targeting the PMN offers a potential strategy for preventing metastasis in high-risk patients. Clinical challenges include the difficulty of detecting the PMN in vivo and the potential for off-target effects on normal tissue homeostasis (Doglioni et al., 2019, Nature Reviews Cancer).

Other names

Pre-metastatic microenvironmentPMNPro-metastatic nichePre-metastatic site

Inhibition of extracellular matrix cross-linking, blockade of bone marrow-derived cell recruitment, and neutralization of tumor-secreted inflammatory cytokines and exosomes.